Jeremy Lewin1,2, Justin Ming Zheng Ma3, Laura Mitchell3, Seline Tam3, Natasha Puri3, Derek Stephens4, Amirrtha Srikanthan5, Philippe Bedard6, Albiruni Razak6, Michael Crump6, David Warr6, Meredith Giuliani7, Abha Gupta3,6. 1. Adolescent and Young Adult Program, Princess Margaret Cancer Centre, Toronto, Canada. Jeremy.Lewin@uhn.ca. 2. Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Ave, Toronto, ON, M5G 2M9, Canada. Jeremy.Lewin@uhn.ca. 3. Adolescent and Young Adult Program, Princess Margaret Cancer Centre, Toronto, Canada. 4. Centre for Biostatistics, Hospital for Sick Children, Toronto, Canada. 5. Department of Medical Oncology, Vancouver Centre, BC Cancer Agency, Vancouver, Canada. 6. Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, 610 University Ave, Toronto, ON, M5G 2M9, Canada. 7. Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, Canada.
Abstract
PURPOSE: Minimal data exist regarding documentation of therapy-associated infertility risk (IR) and fertility preservation (FP) options during the initial oncology consultation prior to systemic therapy. This study investigated factors affecting IR/FP documentation and assessed the effect of implementation of an Adolescent and Young Adult (AYA) program on documentation rates. METHODS: A retrospective review of charts of patients receiving gonadotoxic therapy was undertaken for documentation of IR/FP pre- and post-implementation of an AYA program. Change in documentation rates was assessed using univariate and multiple logistic regression. RESULTS: A total of 173 charts were reviewed. On univariate analysis, IR/FP documentation was less likely if patients had metastatic disease (P < 0.01, P < 0.01), by tumor type (P < 0.01, P < 0.01), received less intensive chemotherapy (P = 0.03, P = 0.06), were older (P = 0.14, P < 0.01), had more children (P < 0.01, P < 0.01), or lacked AYA program involvement (P < 0.01, P < 0.01). FP discussion was more common in males (P = 0.02). On multivariable analysis, more children (P = 0.01, P = 0.03), older age (P < 0.01, P < 0.01), tumor type (P < 0.01, P = 0.01), stage (P = 0.02, NS), relationship (P = 0.03, NS), and lack of AYA involvement (P < 0.01, P < 0.01) were associated with lower rates of IR/FP documentation. Following AYA program implementation, IR/FP rates increased from 56% (CI 46-65%) to 85% (CI 74-92%, P < 0.01) and 54% (CI 45-64%) to 86% (CI 75-93%, P < 0.01), respectively. The effect of AYA program implementation on IR/FP documentation was most noticeable in leukemia, lymphoma, and breast groups (P < 0.01). CONCLUSIONS: Implementing an AYA consultation service at an adult cancer institution had a positive effect on the rates of IR/FP documentation. Specific programming can improve service delivery to AYA cancer patients, and fertility counseling should be integrated for patients undergoing gonadotoxic therapy.
PURPOSE: Minimal data exist regarding documentation of therapy-associated infertility risk (IR) and fertility preservation (FP) options during the initial oncology consultation prior to systemic therapy. This study investigated factors affecting IR/FP documentation and assessed the effect of implementation of an Adolescent and Young Adult (AYA) program on documentation rates. METHODS: A retrospective review of charts of patients receiving gonadotoxic therapy was undertaken for documentation of IR/FP pre- and post-implementation of an AYA program. Change in documentation rates was assessed using univariate and multiple logistic regression. RESULTS: A total of 173 charts were reviewed. On univariate analysis, IR/FP documentation was less likely if patients had metastatic disease (P < 0.01, P < 0.01), by tumor type (P < 0.01, P < 0.01), received less intensive chemotherapy (P = 0.03, P = 0.06), were older (P = 0.14, P < 0.01), had more children (P < 0.01, P < 0.01), or lacked AYA program involvement (P < 0.01, P < 0.01). FP discussion was more common in males (P = 0.02). On multivariable analysis, more children (P = 0.01, P = 0.03), older age (P < 0.01, P < 0.01), tumor type (P < 0.01, P = 0.01), stage (P = 0.02, NS), relationship (P = 0.03, NS), and lack of AYA involvement (P < 0.01, P < 0.01) were associated with lower rates of IR/FP documentation. Following AYA program implementation, IR/FP rates increased from 56% (CI 46-65%) to 85% (CI 74-92%, P < 0.01) and 54% (CI 45-64%) to 86% (CI 75-93%, P < 0.01), respectively. The effect of AYA program implementation on IR/FP documentation was most noticeable in leukemia, lymphoma, and breast groups (P < 0.01). CONCLUSIONS: Implementing an AYA consultation service at an adult cancer institution had a positive effect on the rates of IR/FP documentation. Specific programming can improve service delivery to AYA cancerpatients, and fertility counseling should be integrated for patients undergoing gonadotoxic therapy.
Entities:
Keywords:
Adolescent and young adult; Fertility preservation; Gonadotoxic; Infertility; Oncofertility
Authors: Joyce D Reinecke; Joanne F Kelvin; Sarah R Arvey; Gwendolyn P Quinn; Jennifer Levine; Lindsay N Beck; Andy Miller Journal: J Oncol Pract Date: 2012-05-08 Impact factor: 3.840
Authors: Gwendolyn P Quinn; Susan T Vadaparampil; Clement K Gwede; Cheryl Miree; Lindsey M King; Heather B Clayton; Crystal Wilson; Pamela Munster Journal: J Cancer Surviv Date: 2007-06 Impact factor: 4.062
Authors: Leena Nahata; Teresa K Woodruff; Gwendolyn P Quinn; Lillian R Meacham; Diane Chen; Leslie C Appiah; Courtney Finlayson; Kyle E Orwig; Monica M Laronda; Erin E Rowell; Antoinette Anazodo; Olivia Frias; Julie Sroga Rios; Stacy Whiteside; Veronica Gomez-Lobo; Maggie Dwiggins; Krista J Childress; Holly R Hoefgen; Jennifer M Levine; Yasmin Jayasinghe; Molly Moravek Journal: J Assist Reprod Genet Date: 2020-06 Impact factor: 3.412
Authors: Molly B Moravek; Leslie C Appiah; Antoinette Anazodo; Karen C Burns; Veronica Gomez-Lobo; Holly R Hoefgen; Olivia Jaworek Frias; Monica M Laronda; Jennifer Levine; Lillian R Meacham; Mary Ellen Pavone; Gwendolyn P Quinn; Erin E Rowell; Andrew C Strine; Teresa K Woodruff; Leena Nahata Journal: J Adolesc Health Date: 2019-01-14 Impact factor: 5.012
Authors: Leah Hawkins Bressler; Jennifer E Mersereau; Chelsea Anderson; Juan L Rodriguez; M Elizabeth Hodgson; Clarice R Weinberg; Dale P Sandler; Hazel B Nichols Journal: Cancer Date: 2019-04-23 Impact factor: 6.860
Authors: Natasha N Frederick; James L Klosky; Lillian R Meacham; Gwendolyn P Quinn; Joanne Frankel Kelvin; Brooke Cherven; David R Freyer; Christopher C Dvorak; Julienne Brackett; Sameeya Ahmed-Winston; Elyse Bryson; Eric J Chow; Jennifer Levine Journal: JCO Oncol Pract Date: 2021-10-28
Authors: Janella N Hudson; Nathanael B Stanley; Leena Nahata; Meghan Bowman-Curci; Gwendolyn P Quinn Journal: Expert Rev Qual Life Cancer Care Date: 2017-03-28
Authors: Supriya Behl; Vidhu B Joshi; Reda S Hussein; David L Walker; Kari L Lampat; Anthony G Krenik; Kathrynne M Barud; Jolene R Fredrickson; Terri M Galanits; Katherine J Rian; Adriana M Delgado; Julia H Byrne; Dean Potter; Siobhan T Pittock; Carola A S Arndt; Yulian Zhao; Patricio C Gargollo; Candace F Granberg; Zaraq Khan; Asma J Chattha Journal: J Assist Reprod Genet Date: 2021-01-03 Impact factor: 3.412
Authors: Catherine Benedict; Jen-Ling Nieh; Alexandria L Hahn; Alyssa McCready; Michael Diefenbach; Jennifer S Ford Journal: Support Care Cancer Date: 2020-09-05 Impact factor: 3.359
Authors: Jennifer A H Bell; Victoria Forcina; Laura Mitchell; Seline Tam; Kate Wang; Abha A Gupta; Jeremy Lewin Journal: BMC Cancer Date: 2018-06-04 Impact factor: 4.430